This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Quretech Bio Ab, Washington University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 1,381 
Years Active: 2025
Title: Anders Lindgren: Innovator in Pharmaceutical Chemistry
Introduction
Anders Lindgren is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target gram-positive bacteria. His work has implications for the treatment and prevention of various diseases.
Latest Patents
Anders Lindgren holds a patent for "Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria." This patent describes a compound of Formula I, or a pharmaceutically acceptable salt thereof, which showcases his innovative approach to addressing bacterial infections.
Career Highlights
Throughout his career, Lindgren has worked with various organizations, including Quretech Bio AB and Washington University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Anders Lindgren has collaborated with notable individuals such as Scott J. Hultgren and Jerome Pinkner. These partnerships have enhanced his research and expanded the impact of his inventions.
Conclusion
Anders Lindgren's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to influence the development of treatments for bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile